West Virginia University

Running trials

• Recruiting

  A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes

  NCT07748208· Phase 2· Source

• Recruiting

  ENLIGHT Trial: ESG With Fundal Mucosal Ablation

  NCT07792226· Source

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

  NCT07564141· Phase 3· Source

• Not yet recruiting

  Tailored MgSO4 Supplementation to Reduce Complications in Pediatric Heart Surgery

  NCT06564376· Source

• Recruiting

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· Phase 3· Source

• Recruiting

  An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

  NCT07438405· Phase 2· Source

• Recruiting

  The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

  NCT06796504· Source

• Recruiting

  Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

  NCT07115940· Source

• Recruiting

  A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

  NCT07481383· Phase 1· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· Phase 3· Source

• Recruiting

  A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  NCT07023627· Phase 2· Source

• Enrolling by invitation

  Rate of Allergic Contact Dermatitis and Cosmetic Outcomes

  NCT06957444· Source

• Recruiting

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· Phase 3· Source

• Recruiting

  Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  NCT06972056· Phase 4· Source

• Recruiting

  Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

  NCT06138821· Source

• Active, not recruiting

  MMA Embolization for Refractory Chronic Migraine

  NCT06735833· Source

• Recruiting

  A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  NCT07029399· Phase 1· Source

• Recruiting

  Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

  NCT06626243· Source

• Recruiting

  A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  NCT06246916· Phase 3· Source

• Active, not recruiting

  Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

  NCT06484114· Source

• Recruiting

  VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

  NCT06264180· Phase 3· Source

• Active, not recruiting

  A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

  NCT06401044· Phase 1/2· Source

• Active, not recruiting

  A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

  NCT06226571· Phase 1· Source

• Recruiting

  The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

  NCT02998229· Source

• Recruiting

  Rural Adult and Youth Sun Protection Study

  NCT06439979· Source

• Enrolling by invitation

  ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

  NCT05932615· Source

• Active, not recruiting

  Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)

  NCT06101342· Phase 2· Source

• Recruiting

  PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  NCT05934487· Source

• Active, not recruiting

  CTSN Embolic Protection Trial

  NCT06027788· Source

• Recruiting

  Pregnancy 24/7 Offspring Study

  NCT07172880· Source

• Active, not recruiting

  Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease

  NCT05894343· Phase 1/2· Source

• Enrolling by invitation

  G7 Freedom Constrained Vivacit-E Liners

  NCT05587244· Source

• Active, not recruiting

  A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

  NCT04485949· Phase 2· Source

• Active, not recruiting

  Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

  NCT05478304· Source

• Active, not recruiting

  Buprenorphine Integration Research and Community Health

  NCT05668780· Source

• Active, not recruiting

  Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

  NCT05546580· Phase 1· Source

• Active, not recruiting

  A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

  NCT05444257· Phase 3· Source

• Recruiting

  Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

  NCT04839705· Source

• Active, not recruiting

  Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

  NCT05507151· Source

• Active, not recruiting

  Evolut™ EXPAND TAVR II Pivotal Trial

  NCT05149755· Source

• Recruiting

  A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  NCT04831580· Source

• Active, not recruiting

  SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

  NCT05198674· Source

• Active, not recruiting

  Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Diagnosed AML

  NCT04953780· Phase 1· Source

• Recruiting

  Clarifying the Optimal Application of SLT Therapy Trial

  NCT04967989· Phase 3· Source

• Active, not recruiting

  Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

  NCT04539964· Phase 3· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

  NCT04544449· Phase 3· Source

• Active, not recruiting

  I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination

  NCT04452526· Source

• Active, not recruiting

  Abemaciclib and Letrozole to Treat Endometrial Cancer

  NCT04393285· Phase 2· Source

• Active, not recruiting

  DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

  NCT04165564· Source

• Active, not recruiting

  Bilateral Treatment of Medication Refractory Essential Tremor

  NCT04112381· Source

Showing 50 of 63.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Brain aneurysm3 recruiting
• Childhood cancers3 recruiting
• Melanoma3 recruiting
• Obesity3 recruiting
• Stroke3 recruiting
• Type 2 diabetes3 recruiting
• Multiple myeloma2 recruiting
• Osteoarthritis2 recruiting
• Ovarian cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• Aortic stenosis1 recruiting
• Aplastic anaemia1 recruiting
• Atrial fibrillation1 recruiting
• Cervical cancer1 recruiting
• Chronic kidney disease1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Congenital heart disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Glaucoma1 recruiting
• Graves' disease and hyperthyroidism1 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• Hodgkin lymphoma1 recruiting
• IgA nephropathy1 recruiting
• Kidney cancer1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Migraine1 recruiting
• Multiple sclerosis1 recruiting
• Pancreatic cancer1 recruiting
• Parkinson disease1 recruiting
• Prostate cancer1 recruiting
• Rheumatoid arthritis1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  NCT07214779· Phase 3· Source

• Completed

  Remote Vinyasa Yoga Program for Heart Health

  NCT06961981· Source

• Completed

  NE3107 in Adults With Neurological Symptoms of Long COVID

  NCT06847191· Phase 2· Source

• Terminated

  Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

  NCT06543446· Source

• Completed

  Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

  NCT06506773· Source

• Recruiting

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  NCT06059638· Source

• Recruiting

  Treatment With Endovascular Intervention for STroke Patients With Existing Disability

  NCT05911568· Source

• Recruiting

  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  NCT06084936· Phase 3· Source

• Completed

  Effects of Immulina TM Supplements With PASC Patients

  NCT05524532· Phase 3· Source

• Completed

  A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

  NCT05603312· Phase 1/2· Source

• Completed

  EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

  NCT05093634· Phase 3· Source

• Completed

  A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

  NCT05018650· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· Source

• Completed

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· Phase 3· Source

• Completed

  Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia

  NCT04411849· Source

• Completed

  Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

  NCT04260126· Phase 2· Source

• Terminated

  CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma

  NCT04695977· Phase 2/3· Source

• Completed

  HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

  NCT04571619· Phase 2· Source

• Completed

  A Communication Tool to Assist Older Adults Facing Dialysis Choices

  NCT04466865· Source

• Completed

  Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

  NCT04452149· Source

• Completed

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· Phase 3· Source

• Completed

  Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

  NCT03836209· Phase 2· Source

• Completed

  The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

  NCT03805308· Source

• Completed

  Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

  NCT03941093· Phase 3· Source

• Terminated

  EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04437368· Phase 2· Source

• Completed

  Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption

  NCT03551249· Source

• Terminated

  GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

  NCT03894020· Source

• Completed

  Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

  NCT03424603· Phase 1· Source

• Completed

  Electro-acupuncture (EA) in Children Undergoing Procedures for Congenital Heart Defects.

  NCT03297658· Source

• Completed

  IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project

  NCT03058835· Phase 4· Source

• Completed

  A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

  NCT02815891· Source

• Completed

  A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

  NCT02576431· Phase 2· Source

• Completed

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Source

• Terminated

  Connect® Myeloid Disease Registry

  NCT01688011· Source

• Terminated

  Tritanium® Primary Acetabular Shell Study

  NCT01063751· Source